Patients and Patient Organizations Power Rare Disease Therapies Industry Trends

by Robin Robinson For most of the pharmaceutical industry, the focus on patient centricity is a relatively new phenomenon, and the industry continues to shift its focus to include patients as stakeholders when planning its marketing strategies, clinical trials, and R&D strategies. However, for the rare disease sector, the patient has always been front and center, [&hellip

Read More

Social Media Integration by Acurax Wordpress Developers
Visit Us On InstagramVisit Us On Youtube